Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tong-Yu Lin
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
Cyclosporine, Prednisone, and High-Dose Immunoglobulin Treatment of Angioimmunoblastic T-Cell Lymphoma Refractory to Prior CHOP or CHOP-like Regimen
Chinese Journal of Cancer
Related publications
Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
British Journal of Haematology
Hematology
Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy
Tenri Medical Bulletin
Prognostic Impact of Tumor-Associated Macrophages, Lymphocyte-To-Monocyte and Neutrophil-To-Lymphocyte Ratio in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Performance of Lymphocyte-To-Monocyte Ratio in Diffuse Large B-Cell Lymphoma: An Updated Meta-Analysis of Eleven Reports
OncoTargets and Therapy
Oncology
Pharmacology
The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma
British Journal of Cancer
Cancer Research
Oncology
Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
